BIO.News Newsletter

BIO’s working to ensure small biotechs can access R&D tax deductions and support with grant funding—we have details on that, as well as the launch of TrueTrials. Don't miss BIO CEO Rachel King's op-ed in Fortune about why we need to support women in STEM. (461 words, 2 minutes, 18 seconds)

BIO CEO Rachel King joined Maryland Gov. Wes Moore at the University of Maryland BioPark yesterday, where Maryland’s innovative bioeconomy was on full display. Meanwhile, good news and bad news on bird flu highlights the need for biotech solutions to address human and animal health. (479 words, 2 minutes, 23 seconds)

New data highlights the need for the most vulnerable to get updated vaccines, while a growing body of evidence highlights the impact of climate change on our health (and what biotech can do on both fronts). (432 words, 2 minutes, 9 seconds)

It’s the last week of Hispanic Heritage Month, a chance to look at inequities in health care and how we can overcome them. Plus, how synbio is removing greenhouse gas emissions and creating better products. (512 words, 2 minutes, 33 seconds)

BIO Chair Dr. Ted Love won a prestigious award for his commitment to sickle cell disease patients—here’s what he says about the future of treatments. Plus, September heat shattered records, by a record margin—but biotech offers solutions. (456 words, 2 minutes, 16 seconds)

A look at what’s driving vaccine hesitancy in this critical moment for several respiratory viruses—plus, new developments in CRISPR that could enable more efficient medical treatment delivery in living humans. (464 words, 2 minutes, 19 seconds)

Top legal experts explain why laws like Bayh-Dole and Section 1498 should not be used to control prices, and Novavax becomes the third updated COVID shot cleared for use in the U.S. as cases surge. (553 words, 2 minutes, 19 seconds)

Good news out of the D.C. District Court, which struck down a rule that allowed insurers and PBMs to pocket copay assistance intended for patients. We have details, plus today’s new episode of the I am BIO Podcast explores why we need women leadership in biotech and a lot more news.  (754 words, 3 minutes, 46 seconds)

A very quick update on what’s been happening on Capitol Hill and why it matters to biotech—plus, meet BIO’s new agriculture and environment working groups. (556 words, 2 minutes, 46 seconds)

While we wait to see what happens with government funding before tomorrow’s deadline, we have news on a new PBM transparency bill, a new collaboration to help patients enroll in clinical trials, and a win for patients with Pompe disease. (590 words, 2 minutes, 57 seconds)